“…Consistently, in addition to the well‐documented allergic contact dermatitis by topically applied LAs [1,2,14], positive patch tests (PT) and T cell involvement have also been observed in subjects experiencing contact dermatitis [3,5,15–17] or other adverse reactions [17–19] to LA injections. Furthermore, delayed local or systemic reactions have been reported in association with delayed positive IST results with LAs in many patients [4,5], some of whom were indeed shown later on to display delayed‐type hypersensitivity to these drugs by in vivo specific PT [5,18,19] or in vitro specific T cell responses [17]. For these reasons, it has been proposed to perform IST with different, multiple concentrations and to evaluate possible delayed reactions after 24 h or more before patients can be permitted to undergo subcutaneous challenge [4,5].…”